M. Radhakrishnan

发表

H. Cardoso, M. Radhakrishnan, Patrícia Costa, 2019 .

Anti-anxiety effect of a novel 5-HT3 receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2014, Indian journal of pharmacology.

Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2015, Steroids.

DEPRESSION ASSOCIATED CO-MORBID CARDIOVASCULAR AND METABOLIC COMPLICATIONS

M. Radhakrishnan, Devadoss Thangaraj, Pandey Dilip, 2010 .

Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2014, Physiology & Behavior.

Anxiolytic Effect of a Novel 5-HT3 Receptor Antagonist (4-Phenylpiperazin-1-yl) (Quinoxalin-2-yl) Methanone (4a) in a Battery of Behavioral Models for Anxiety in Mice.

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2013 .

Ondansetron attenuates depression co-morbid with obesity in obese mice subjected to chronic unpredictable mild stress; an approach using behavioral battery tests

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2014, Metabolic Brain Disease.

QCM‐4 a novel 5‐HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2014, The Journal of pharmacy and pharmacology.

Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2014, Metabolic Brain Disease.

Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models

M. Radhakrishnan, Minasri Borah, Rajkumar Ramamoorthy, 2008, Behavioural pharmacology.

Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats

S. Bhatt, Deepali Gupta, Y. Kurhe, 2013, Indian journal of psychological medicine.

EFFECT OF A NOVEL 5-HT3 RECEPTOR ANTAGONIST 3-METHOXY-N-P-TOLYLQUINOXALIN-2- CARBOXAMIDE (QCM-4) ON THE ACUTE AND CHRONIC RODENT MODELS OF DEPRESSION

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2013 .

5HT3 receptors: Target for new antidepressant drugs

Deepali Gupta, M. Radhakrishnan, V. Prabhakar, 2016, Neuroscience & Biobehavioral Reviews.

Musicolinguistic Approaches to the Study of Song

M. Radhakrishnan, 2019, Performance Research.

The Value of Ethnographic Research on Music: An Introduction

M. Radhakrishnan, Georgia Curran, 2021 .

Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2014, European journal of pharmacology.

Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety.

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2014, European journal of pharmacology.

Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2015, Journal of pharmacy & bioallied sciences.

5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: Modulation of hypothalamic–pituitary–adrenocortical and brain serotonergic system

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2014, Pharmacology Biochemistry and Behavior.

‘Shake it and Dance': Portuguese Burgher Identity and the Performance of Káfriinha

M. Radhakrishnan, 2021 .

Role of Serotonin Type-1A/B (Hydroxytryptamine) Receptors in Depression Revisited

Deepali Gupta, M. Radhakrishnan, V. Prabhakar, 2013 .

Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system.

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2014, European journal of pharmacology.

Diabetes-associated depression: The serotonergic system as a novel multifunctional target

Deepali Gupta, M. Radhakrishnan, V. Prabhakar, 2015, Indian journal of pharmacology.

Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice

S. Bhatt, A. Jindal, M. Radhakrishnan, 2014, Indian journal of pharmacology.

Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models

M. Radhakrishnan, Minasri Borah, Rajkumar Ramamoorthy, 2008, Behavioural pharmacology.

Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2014, Acta Pharmacologica Sinica.

South Indian Carnatic singing and Irish Sean-nós - an ethnographic, musical and linguistic comparison

M. Radhakrishnan, 2016 .

Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2014, Metabolic Brain Disease.

Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2014, Physiology & Behavior.

EFFECT OF A NOVEL 5-HT3 RECEPTOR ANTAGONIST 3-METHOXY-N-P-TOLYLQUINOXALIN-2- CARBOXAMIDE (QCM-4) ON THE ACUTE AND CHRONIC RODENT MODELS OF DEPRESSION

Deepali Gupta, Y. Kurhe, M. Radhakrishnan, 2013 .